Jennison Associates
LLY icon

Jennison Associates’s Eli Lilly LLY Stock Holding History

Jennison Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-260,000
Closed -$19.1M – 733
2016
Q4 		$19.1M Buy
260,000
+130,000
+100% +$9.68M 0.02% 415
2016
Q3 		$10.4M Hold
130,000
– – 0.01% 471
2016
Q2 		$10.2M Buy
+130,000
New +$9.79M 0.01% 465

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates's LLY Position: Q1 2026 in Review

Jennison Associates reduced its Eli Lilly (LLY) stake by 1.4% in Q1 2026, selling an estimated $73.8M and leaving 5,060,878 shares worth $4.65B. The position accounts for 3.2% of the portfolio, ranked #7.

Jennison Associates first reported a position in LLY in Q3 2013 and has held it in 50 quarters since. The position peaked at $6.55B in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Jennison Associates held 5,060,878 shares of Eli Lilly worth $4.65B as of Q1 2026.
  • Jennison Associates sold 72,798 Eli Lilly shares in Q1 2026, an estimated $73.8M.
  • Eli Lilly made up 3.2% of Jennison Associates's portfolio in Q1 2026, its #7 holding.
  • Jennison Associates first reported a position in Eli Lilly in Q3 2013 and has held it in 50 quarters since.
  • Jennison Associates's Eli Lilly position peaked at $6.55B in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.